Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers-Reference-Cited by-同舟云学术

Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers

Published:2020-10-18 Issue:3 Volume:109 Page:646-657
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Neuvonen Mikko¹²³,Hirvensalo Päivi¹²³,Tornio Aleksi¹²³,Rago Brian⁴,West Mark⁴,Lazzaro Sarah⁴,Mathialagan Sumathy⁴,Varma Manthena⁴,Cerny Matthew A.⁴,Costales Chester⁴,Ramanathan Ragu⁴,Rodrigues A. David⁴,Niemi Mikko¹²³

Affiliation:

1. Department of Clinical Pharmacology University of Helsinki Helsinki Finland

2. HUS Diagnostic Center Helsinki University Hospital Helsinki Finland

3. Individualized Drug Therapy Research Program University of Helsinki Helsinki Finland

4. ADME Sciences, Medicine Design Pfizer Inc. Groton Connecticut USA

Funder

H2020 European Research Council

Health Research

Sigrid Juséliuksen Säätiö

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2053

Reference48 articles.

1. Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation

2. Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions

3. European Medicines Agency.Guideline on the investigation of drug interactions (2012). Accessed May 10 2020.

4. US Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry:clinical drug interaction studies – cytochrome P450 enzyme‐ and transporter‐mediated drug interactions (2020). Accessed May 10 2020.

5. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4;Clinical Pharmacology & Therapeutics;2024-07-22

2. Expanding Role of Endogenous Biomarkers for Assessment of Transporter Activity in Drug Development: Current Applications and Future Horizon;Pharmaceutics;2024-06-25

3. Comprehensive Clinical and Genetic Analyses of Circulating Bile Acids and Their Associations With Diabetes and Its Indices;Diabetes;2024-05-03

4. Genome‐Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP;Clinical Pharmacology & Therapeutics;2024-03-17

5. Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function;Clinical and Translational Science;2024-03